A BTK-Inhibitor Reduced Number of Gadolinium-Enhancing... : Neurology Today - LWW Journals

A BTK-Inhibitor Reduced Number of Gadolinium-Enhancing... : Neurology Today  LWW Journals

Researchers reported that a new drug targeting B cells in patients with multiple sclerosis reduced gadolinium-enhancing lesions but the study was not powered ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases